Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis
Adam Ioannou(The Royal Free Hospital), Marianna Fontana(Amyloidosis Foundation), Daniel Knight(University College London), Peter Kellman(National Institutes of Health), Helen J. Lachmann(Royal Free London NHS Foundation Trust), Liza Chacko(Imperial College London), Ashutosh Wechelakar(MACOM (United States)), Lucia Venneri(MACOM (United States)), Philip N. Hawkins(The Royal Free Hospital), James Brown(MACOM (United States)), Charlotte Manisty(National Institutes of Health), Brendan Wisniowski(The Royal Free Hospital), Rishi Patel(Texas Tech University), Julian D. Gillmore(Alnylam Pharmaceuticals (United States)), Carol Whelan(The Royal Free Hospital), Yousuf Razvi(The Royal Free Hospital), Aldostefano Porcari(Azienda Sanitaria Universitaria Integrata di Trieste), Tushar Kotecha(Royal Society), Ana Martinez–Naharro(Children's Cancer and Leukaemia Group), James Moon(University of Michigan)
Cited by 53
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k